{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:41:35Z","timestamp":1773416495483,"version":"3.50.1"},"reference-count":67,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Plasma membrane-bound carboxypeptidase-D (CPD) cleaves C-terminal arginine from extracellular substrates. In the cell, arginine is converted to nitric oxide (NO). We have reported that up-regulation of CPD mRNA\/protein levels by 17\u03b2-estradiol and prolactin (PRL) in breast cancer cells, and by testosterone in prostate cancer cells, increased NO production and cell survival. The CPD promoter contains a consensus \u03b3-interferon-activated sequence (GAS) and 3 putative androgen response elements (ARE.1, ARE.2, ARE.3) that could potentially bind PRL-activated transcription factor Stat5 (signal transducer and activator of transcription 5) and the liganded androgen receptor (AR), respectively. This study showed that synthetic androgen R1881 and PRL elevated CPD mRNA\/protein levels in human MCF-7 and T47D breast cancer cells in a time-\/dose-dependent manner. PRL\/R1881-elevated CPD expression was blocked by actinomycin-D, and a CPD promoter construct containing these GAS and AREs was stimulated by PRL or R1881, indicating transcriptional regulation by both hormones. Luciferase reporter assays showed that GAS and the adjacent ARE.1 only were active. Mutation of GAS in the \u0394GAS-CPD construct (ARE.1 intact) abolished CPD promoter activity in response to PRL and, surprisingly, to R1881 as well. \u0394GAS-CPD promoter activity was restored by PRL+R1881 in combination, and enhanced by ectopic Stat5, but abolished by Stat5 gene knockdown. Chromatin immunoprecipitation analysis confirmed binding of activated Stat5 and liganded AR to GAS and ARE.1, respectively. Activated Stat5 also induced binding of unliganded AR to ARE.1, and liganded AR induced binding of unactivated Stat5 to GAS. In summary, PRL and R1881, acting through Stat5 and AR, act cooperatively to stimulate CPD gene transcription in breast cancer cells.<\/jats:p>","DOI":"10.1210\/me.2013-1202","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T17:38:23Z","timestamp":1389893903000},"page":"331-343","source":"Crossref","is-referenced-by-count":9,"title":["Prolactin\/Stat5 and Androgen R1881 Coactivate Carboxypeptidase-D Gene in Breast Cancer Cells"],"prefix":"10.1210","volume":"28","author":[{"given":"Samir","family":"Koirala","sequence":"first","affiliation":[{"name":"Department of Biochemistry & Molecular Biology (S.K., L.N.T., C.K.L.T.), Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn N.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Biochemistry & Molecular Biology (S.K., L.N.T., C.K.L.T.), Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine K. L.","family":"Too","sequence":"additional","affiliation":[{"name":"Department of Biochemistry & Molecular Biology (S.K., L.N.T., C.K.L.T.), Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"},{"name":"Department of Obstetrics & Gynaecology (C.K.L.T.), Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613312429700_B1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.1998.tb01577.x","article-title":"Cellular carboxypeptidases","volume":"161","author":"Skidgel","year":"1998","journal-title":"Immunol Rev"},{"key":"2020071613312429700_B2","doi-asserted-by":"crossref","first-page":"25007","DOI":"10.1074\/jbc.270.42.25007","article-title":"Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary","volume":"270","author":"Song","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071613312429700_B3","doi-asserted-by":"crossref","first-page":"28884","DOI":"10.1074\/jbc.271.46.28884","article-title":"Tissue distribution and characterization of soluble and membrane-bound forms of metallocarboxypeptidase D","volume":"271","author":"Song","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071613312429700_B4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/bj3270081","article-title":"Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains","volume":"327","author":"Tan","year":"1997","journal-title":"Biochem J"},{"key":"2020071613312429700_B5","doi-asserted-by":"crossref","first-page":"28887","DOI":"10.1074\/jbc.274.41.28887","article-title":"Characterization of the enzymatic properties of the first and second domains of metallocarboxypeptidase D","volume":"274","author":"Novikova","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071613312429700_B6","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1074\/jbc.274.21.14759","article-title":"Localization of metallocarboxypeptidase D in AtT-20 cells. Potential role in prohormone processing","volume":"274","author":"Varlamov","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071613312429700_B7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jcb.10112","article-title":"Analysis of the carboxypeptidase D cytoplasmic domain: implications in intracellular trafficking","volume":"85","author":"Kalinina","year":"2002","journal-title":"J Cell Biochem"},{"key":"2020071613312429700_B8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1124\/mol.59.5.1324","article-title":"Carboxypeptidase D is up-regulated in RAW 264.7 macrophages and stimulates nitric oxide synthesis by cells in arginine-free medium","volume":"59","author":"Hadkar","year":"2001","journal-title":"Mol Pharmacol"},{"key":"2020071613312429700_B9","doi-asserted-by":"crossref","first-page":"L35","DOI":"10.1152\/ajplung.00346.2003","article-title":"Carboxypeptidase-mediated enhancement of nitric oxide production in rat lungs and microvascular endothelial cells","volume":"287","author":"Hadkar","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2020071613312429700_B10","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1210\/en.2008-0145","article-title":"Prolactin and estrogen up-regulate carboxypeptidase-D to promote nitric oxide production and survival of MCF-7 breast cancer cells","volume":"149","author":"Abdelmagid","year":"2008","journal-title":"Endocrinology"},{"key":"2020071613312429700_B11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/pros.21446","article-title":"Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells","volume":"72","author":"Thomas","year":"2012","journal-title":"Prostate"},{"key":"2020071613312429700_B12","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10875-007-9118-7","article-title":"Carboxypeptidase D: a novel TGF-beta target gene dysregulated in patients with lupus erythematosus","volume":"27","author":"Hoff","year":"2007","journal-title":"J Clin Immunol"},{"key":"2020071613312429700_B13","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1158\/0008-5472.CAN-05-2900","article-title":"Tumors face NO problems?","volume":"66","author":"Lancaster","year":"2006","journal-title":"Cancer Res"},{"key":"2020071613312429700_B14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc1910","article-title":"The role of nitric oxide in tumour progression","volume":"6","author":"Fukumura","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2020071613312429700_B15","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","article-title":"Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly","volume":"271","author":"Beckman","year":"1996","journal-title":"Am J Physiol"},{"key":"2020071613312429700_B16","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1073\/pnas.92.10.4392","article-title":"Roles of nitric oxide in tumor growth","volume":"92","author":"Jenkins","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613312429700_B17","doi-asserted-by":"crossref","first-page":"37679","DOI":"10.1074\/jbc.274.53.37679","article-title":"Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53","volume":"274","author":"Mortensen","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071613312429700_B18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1006\/bbrc.1999.2003","article-title":"Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells","volume":"267","author":"Chazotte-Aubert","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071613312429700_B19","first-page":"1215","article-title":"Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors","volume":"79","author":"Reveneau","year":"1999","journal-title":"Lab Invest"},{"key":"2020071613312429700_B20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/14796694.2.2.275","article-title":"Nitric oxide and hormones in breast cancer: allies or enemies?","volume":"2","author":"Pance","year":"2006","journal-title":"Future Oncol"},{"key":"2020071613312429700_B21","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1158\/0008-5472.CAN-05-4033","article-title":"Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity","volume":"66","author":"Huh","year":"2006","journal-title":"Cancer Res"},{"key":"2020071613312429700_B22","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/sj.onc.1209984","article-title":"Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression","volume":"26","author":"Cronauer","year":"2007","journal-title":"Oncogene"},{"key":"2020071613312429700_B23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jgm.1495","article-title":"Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer","volume":"12","author":"Coulter","year":"2010","journal-title":"J Gene Med"},{"key":"2020071613312429700_B24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI35079","article-title":"Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer","volume":"119","author":"Nanni","year":"2009","journal-title":"J Clin Invest"},{"key":"2020071613312429700_B25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1535-6108(03)00168-5","article-title":"Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice","volume":"4","author":"Gratton","year":"2003","journal-title":"Cancer Cell"},{"key":"2020071613312429700_B26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1042\/BST0351364","article-title":"Novel agents for cancer prevention based on nitric oxide","volume":"35","author":"Rigas","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"2020071613312429700_B27","first-page":"2591","article-title":"Prolactin synthesis and secretion by human breast cancer cells","volume":"55","author":"Ginsburg","year":"1995","journal-title":"Cancer Res"},{"key":"2020071613312429700_B28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1026325630359","article-title":"Prolactin as an autocrine\/paracrine factor in breast tissue","volume":"2","author":"Clevenger","year":"1997","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2020071613312429700_B29","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1210\/endo.138.12.5605","article-title":"Expression of prolactin and its receptor in human breast carcinoma","volume":"138","author":"Reynolds","year":"1997","journal-title":"Endocrinology"},{"key":"2020071613312429700_B30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.onc.1207245","article-title":"Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice","volume":"23","author":"Peirce","year":"2004","journal-title":"Oncogene"},{"key":"2020071613312429700_B31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/mend.16.1.0762","article-title":"PRL modulates cell cycle regulators in mammary tumor epithelial cells","volume":"16","author":"Schroeder","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2020071613312429700_B32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0960-0760(95)00005-K","article-title":"Androgens induce divergent proliferative responses in human breast cancer cell lines","volume":"52","author":"Birrell","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071613312429700_B33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone","volume":"24","author":"Labrie","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071613312429700_B34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/er.2003-0016","article-title":"Testosterone effects on the breast: implications for testosterone therapy for women","volume":"25","author":"Somboonporn","year":"2004","journal-title":"Endocr Rev"},{"key":"2020071613312429700_B35","first-page":"4610","article-title":"The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture","volume":"36","author":"Lippman","year":"1976","journal-title":"Cancer Res"},{"key":"2020071613312429700_B36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0960-0760(95)00228-6","article-title":"Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids","volume":"56","author":"Hackenberg","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071613312429700_B37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0895-4356(94)00201-Z","article-title":"Serum prolactin levels and their relationship to survival in women with operable breast cancer","volume":"48","author":"Wang","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"2020071613312429700_B38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.2910340307","article-title":"Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer","volume":"34","author":"Holtkamp","year":"1984","journal-title":"Int J Cancer"},{"key":"2020071613312429700_B39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jnci\/91.7.629","article-title":"Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women","volume":"91","author":"Hankinson","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2020071613312429700_B40","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-130-4_Part_1-199902160-00004","article-title":"Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group","volume":"130","author":"Cauley","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020071613312429700_B41","first-page":"533","article-title":"Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk","volume":"5","author":"Dorgan","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020071613312429700_B42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114596","article-title":"Sex hormone levels in serum in relation to the development of breast cancer","volume":"125","author":"Wysowski","year":"1987","journal-title":"Am J Epidemiol"},{"key":"2020071613312429700_B43","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","article-title":"Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women","volume":"90","author":"Hankinson","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2020071613312429700_B44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcb.23022","article-title":"CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines","volume":"112","author":"Abdelmagid","year":"2011","journal-title":"J Cell Biochem"},{"key":"2020071613312429700_B45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/endo.142.3.8041","article-title":"Identification and nuclear localization of a novel prolactin and cytokine-responsive carboxypeptidase D","volume":"142","author":"Too","year":"2001","journal-title":"Endocrinology"},{"key":"2020071613312429700_B46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2265.2004.02173.x","article-title":"Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis","volume":"62","author":"Sader","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613312429700_B47","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S1567-5769(02)00149-2","article-title":"Structural characterization of the human carboxypeptidase D gene and its promoter","volume":"2","author":"Timblin","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"2020071613312429700_B48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/0008-5472.CAN-07-2972","article-title":"Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells","volume":"68","author":"Tan","year":"2008","journal-title":"Cancer Res"},{"key":"2020071613312429700_B49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1096\/fj.04-2386com","article-title":"Identification of a novel functional androgen response element within hPar1 promoter: implications to prostate cancer progression","volume":"19","author":"Salah","year":"2005","journal-title":"FASEB J"},{"key":"2020071613312429700_B50","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/mend.16.7.0875","article-title":"Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor","volume":"16","author":"Carsol","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2020071613312429700_B51","first-page":"23","article-title":"Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene","volume":"7","author":"Rennie","year":"1993","journal-title":"Mol Endocrinol"},{"key":"2020071613312429700_B52","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1210\/mend-5-12-1921","article-title":"The promoter of the prostate-specific antigen gene contains a functional androgen responsive element","volume":"5","author":"Riegman","year":"1991","journal-title":"Mol Endocrinol"},{"key":"2020071613312429700_B53","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"2020071613312429700_B54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0962-8924(99)01709-2","article-title":"Association of STATs with relatives and friends","volume":"10","author":"Chatterjee-Kishore","year":"2000","journal-title":"Trends Cell Biol"},{"key":"2020071613312429700_B55","doi-asserted-by":"crossref","first-page":"30264","DOI":"10.1074\/jbc.270.51.30264","article-title":"Stat1 depends on transcriptional synergy with Sp1","volume":"270","author":"Look","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071613312429700_B56","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/sj.onc.1203522","article-title":"Modulation of STAT signaling by STAT-interacting proteins","volume":"19","author":"Shuai","year":"2000","journal-title":"Oncogene"},{"key":"2020071613312429700_B57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/edrv-16-5-559","article-title":"Growth factors in breast cancer","volume":"16","author":"Dickson","year":"1995","journal-title":"Endocr Rev"},{"key":"2020071613312429700_B58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1018730519839","article-title":"Role of the androgen receptor in human breast cancer","volume":"3","author":"Birrell","year":"1998","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2020071613312429700_B59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2001-0036","article-title":"The role of prolactin in mammary carcinoma","volume":"24","author":"Clevenger","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071613312429700_B60","first-page":"7162","article-title":"Improved measurement of androgen receptors in human breast cancer","volume":"49","author":"Lea","year":"1989","journal-title":"Cancer Res"},{"key":"2020071613312429700_B61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/modpathol.3880021","article-title":"Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site","volume":"13","author":"Bayer-Garner","year":"2000","journal-title":"Mod Pathol"},{"key":"2020071613312429700_B62","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/annonc\/mdp510","article-title":"Expression of androgen receptors in primary breast cancer","volume":"21","author":"Park","year":"2010","journal-title":"Ann Oncol"},{"key":"2020071613312429700_B63","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/bjc.1996.513","article-title":"Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer","volume":"74","author":"Hall","year":"1996","journal-title":"Br J Cancer"},{"key":"2020071613312429700_B64","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/0959-8049(96)00112-8","article-title":"The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters","volume":"32A","author":"Kuenen-Boumeester","year":"1996","journal-title":"Eur J Cancer"},{"key":"2020071613312429700_B65","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM198710083171509","article-title":"Proto-oncogenes and human cancers","volume":"317","author":"Slamon","year":"1987","journal-title":"N Engl J Med"},{"key":"2020071613312429700_B66","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1074\/jbc.272.29.18250","article-title":"Functional interactions between the estrogen receptor and the transcription activator Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 io promoter","volume":"272","author":"Batistuzzo de Medeiros","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071613312429700_B67","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/nar\/25.12.2424","article-title":"Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-\u03baB site","volume":"25","author":"Galien","year":"1997","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/28\/3\/331\/8902951\/mend0331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/28\/3\/331\/8902951\/mend0331.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:02:28Z","timestamp":1594944148000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/28\/3\/331\/2623219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2013-1202","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,1]]}}}